Trailing-twelve-month (TTM) revenue is $3.64 Billion with a year-over-year growth of (0.76%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $904,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $961,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-26 |
| Q1 FY2026Period ended 2026-03-31 | $880,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $898,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $3,643,000,000 |
Current P/S: $2,095,417,104 market capitalization ÷ $3,643,000,000 TTM revenue = 0.58x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $898.00M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:16:14.031Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2022-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20172017-12-31 · USD | FY20182018-12-31 · USD | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD |
|---|---|---|---|---|---|---|
| Consumables Segment | $1.8B | $1.9B | $1.7B | $1.4B | $1.7B | $1.6B |
| Technologies And Equipment | $2.2B | $2.1B | $2.3B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Europe | $1.4B | $1.7B | $1.6B | $1.6B | $1.5B | $1.6B |
| Other Foreign | $846M | $1.1B | $971M | $978M |
$3.64B
$3.64 Billion
(0.76%)
vs. $3.67B a year ago (TTM)
+1.96%
5 Year compound annual growth rate
1 Year
(0.76%)
3 Year
(2.55%)
5 Year
+1.96%
10 Year
+1.58%
15 Year
+3.14%
20 Year
+3.68%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $3.68B | ($113.00M) | (2.98%) |
| 2024 | $3.79B | ($172.00M) | (4.34%) |
| 2023 | $3.96B | +$43.00M | +1.10% |
| 2022 | $3.92B | ($309.00M) | (7.30%) |
| 2021 | $4.23B | +$892.00M | +26.71% |
| 2020 |
TTM Growth
(0.76%)
3-Year CAGR
(2.55%)
5-Year CAGR
(2.11%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:16:14.031Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $2.5B |
| $2.3B |
| $922M |
| UNITED STATES | $1.1B | $1.5B | $1.4B | $1.4B | $1.3B | $1.2B |
|---|
| $3.34B |
| ($683.00M) |
| (16.98%) |
| 2019 | $4.02B | +$35.70M | +0.90% |
| 2018 | $3.99B | ($7.10M) | (0.18%) |
| 2017 | $3.99B | +$248.10M | +6.62% |
| 2016 | $3.75B | +$1.07B | +40.05% |
